Загрузка...
Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy
Engineered protein therapeutics offer advantages, including strong target affinity, selectivity, and low toxicity, but like natural proteins can be susceptible to proteolytic degradation, thereby limiting their effectiveness. A compelling therapeutic target is mesotrypsin, a protease upregulated wit...
Сохранить в:
| Опубликовано в: : | Biochem J |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4898653/ https://ncbi.nlm.nih.gov/pubmed/26957636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BJ20151410 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|